Arenobufagin induces cell apoptosis by modulating the cell cycle regulator claspin and the JNK pathway in nasopharyngeal carcinoma cells

Hsin-Yu Ho,Mu-Kuan Chen,Chia-Chieh Lin,Yu-Sheng Lo,Yi-Ching Chuang,Ming-Ju Hsieh
DOI: https://doi.org/10.1080/14728222.2024.2348014
IF: 6.797
2024-04-29
Expert Opinion on Therapeutic Targets
Abstract:Background The high recurrence rate and incidence of distant metastasis of nasopharyngeal carcinoma (NPC) result in poor prognosis. It is necessary to identify natural compounds that can complement combination radiation therapy. Arenobufagin is commonly used for heart diseases and liver cancer, but its effectiveness in NPC is unclear.
pharmacology & pharmacy
What problem does this paper attempt to address?